New tools to support AAV manufacturing
With the rapid developments in the field of gene therapy, the use of viral
vectors, especially AAV, to treat various monogenic, inherited diseases in
human patients is gaining momentum. Nonetheless, there are still options to
optimize the production of such vectors in mammalian cells.